DNA damage in patients with untreated cancer as measured by the sperm chromatin structure assay
Authors:
- Rakesh K SharmaRSRakesh K Sharma
- Ashok AgarwalAAAshok Agarwal
- 1 March 2001
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 75 (3) , 469-475
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Prediction of posttreatment spermatogenesis in patients with testicular cancer by flow cytometric sperm chromatin structure assayCytometry, 1997
- Paternal Cigarette Smoking and the Risk of Childhood Cancer Among Offspring of Nonsmoking MothersJNCI: Journal of the National Cancer Institute, 1997
- Use of the guanine-cytosine (GC) specific fluorochrome, chromomycin A3, as an indicator of poor sperm morphologyJournal of Assisted Reproduction and Genetics, 1996
- Sperm selection methods for intracytoplasmic sperm injection (ICSI) in andrological patientsJournal of Assisted Reproduction and Genetics, 1996
- Value of Clinical Diagnosis in Predicting the Quality of Cryopreserved Sperm from Cancer PatientsJournal of Urology, 1996
- Features of apoptotic cells measured by flow cytometryCytometry, 1992
- Longitudinal study of semen quality of unexposed workersReproductive Toxicology, 1988
- Flow cytometric analysis of mouse spermatogenic function following exposure to ethylnitrosoureaCytometry, 1985
- Thermal denaturation of DNA in situ as studied by acridine orange staining and automated cytofluorometryExperimental Cell Research, 1975
- Changes in deoxyribonucleoprotein during spermiogenesis in the bullExperimental Cell Research, 1970